Malignant Hyperthermia Diagnostics, Treatment and Anaesthetic Management;Maligne Hyperthermie Diagnostik, Therapie und Narkoseführung

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 44, Issue 11-12, 2009, Pages 758-763

  Schuster, Frank ^a   Müller Reible, Clemens R ^b  

^a Funktionsoberarzt An der Klinik   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INHALATION ANESTHETIC AGENT; SUXAMETHONIUM;

ANESTHESIA; ANESTHESIA COMPLICATION; HUMAN; MALIGNANT HYPERTHERMIA; REVIEW; SYMPTOM;

ANESTHESIA; ANESTHESIA, CONDUCTION; BIOPSY; HUMANS; MALIGNANT HYPERTHERMIA; MUSCLE, SKELETAL;

EID: 70450199081     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0029-1242125     Document Type: Review

References (20)

1. Brewer GE. Heat-stroke as a post-operative complication. J Am Med Assoc 1900; 35: 1685
2. Gibson CL, Tuttle JJ. Heat stroke as a post-operative complication. Med News (NY) 1900; 77: 883-884
3. Denborough MA, Lovell RRH. Anaesthetic deaths in a family. Lancet 1960; 2: 45
4. Harrison GG. Control of malignant hyperpyrexia syndrome in MHS swine by dantrolene sodium. Br J Anaesth 1975; 47: 62-65
5. Kalow W, Britt BA, Terrau ME, Haist C. Metabolic error of muscle metabolism after recovery from malignant hyper-thermia. Lancet 1970; 2: 895-898
6. Ellis FR, Harriman DGH, Keaney NP, Kyei-Mensah K, Tyrell JH. Halothane-incuced muscle contracture as a cause of hy-perpyrexia. Br J Anaesth 1971; 43: 721-722
7. Urwyler A, Deufel T, McCarthy T, West S. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001; 86: 283-287
8. Hartung E, Anetseder M, Olthoff D, Deutrich C, Lehmann-Horn F, Baur Ch, Tegazzin V, Doetsch S, Quasthoff S., Hof-mann M, Schwefl Er B, Jantzen J.P, Wappler F, Scholz J. Die regionale Verbreitung der Malignen-Hyperthermie- Veranla-gung in Deutschland: Stand 1997. Anaesthesiol Intensiv-med Notfallmed Schmerzther 1998; 33: 238-243
9. Melzer W, Herrmann-Frank A, Lüttgau HC. The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fi bers. Biochem Biophys Acta 1995; 1241: 59-116
10. Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, Louis CF. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 1998; 263: 9310-9315
11. Mickelson JR, Louis CF. Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol Rev 1996; 76: 537-592
12. McCarthy TV, Healy JM, Heff ron JJ, Lehane M, Deufel T, Leh-mann-Horn F. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 1990; 343: 562-564
13. Monnier N, Procaccio V, Stieglitz P, Lunardi J. Malignant-hy-perthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensiti-ve L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am J Hum Genet 1997; 60:1316-1325
14. Kunst G, Graf BM, Schreiner R, Martin R, Fink RH. Diff eren-tial eff ects of sevofl urane, isofl urne, and halothane on ca2+ release from the sarcoplamsic reticulum of skeletal muscle. Anesthesiology 1999; 91: 179-186
15. Schuster F, Anetseder M, Schöll H, Roewer N. Halothan und Succinylcholin sind keine vergleichbaren Trigger bei malig-ne Hyperthermie-suszeptiblen Schweinen Anästh Intensiv-med 2004; 45: 717-718
16. Loghmanee F, Tobak M. Fatal malignant hyperthermia associated with recreational cocaine and ethanol abuse. Am J Forensic Med Pathol 1986; 7: 246-248
17. Merigian KS, Roberts JR. Cocaine intosication: hyperpyre-xia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 1987; 25: 135-148
18. Anetseder M, Hartung E, Klepper S, Reichmann H. Gasoline vapors induce servere rhabdomyolysis. Neurology 1994; 44: 2393-23965
19. Wappler F, Fiege M, Steinfath M, Agarwal K, Scholz J, Singh S, Matschke J, Schulte am Esch J. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 2001; 94: 95-100
20. Anetseder M, Ritter L, Horbaschek H, Hartung E, Roewer N. The impact of 4-chloro-m-cresol in heparin formulas on malignant hyperthermia: in vitro and in vivo. Acta Anesthe siol Scand 2000; 44: 338-342